SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-22-012232
Filing Date
2022-08-04
Accepted
2022-08-04 16:27:52
Documents
47
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q nxtc-20220630x10q.htm   iXBRL 10-Q 1077125
2 EX-31.1 nxtc-20220630xex31d1.htm EX-31.1 12901
3 EX-31.2 nxtc-20220630xex31d2.htm EX-31.2 12682
4 EX-32.1 nxtc-20220630xex32d1.htm EX-32.1 12251
  Complete submission text file 0001558370-22-012232.txt   4307220

Data Files

Seq Description Document Type Size
5 EX-101.SCH nxtc-20220630.xsd EX-101.SCH 22690
6 EX-101.CAL nxtc-20220630_cal.xml EX-101.CAL 34652
7 EX-101.DEF nxtc-20220630_def.xml EX-101.DEF 87119
8 EX-101.LAB nxtc-20220630_lab.xml EX-101.LAB 266501
9 EX-101.PRE nxtc-20220630_pre.xml EX-101.PRE 177368
41 EXTRACTED XBRL INSTANCE DOCUMENT nxtc-20220630x10q_htm.xml XML 777233
Mailing Address 9000 VIRGINIA MANOR ROAD, SUITE 200 BELTSVILLE MD 20705
Business Address 9000 VIRGINIA MANOR ROAD, SUITE 200 BELTSVILLE MD 20705 240-399-4900
NextCure, Inc. (Filer) CIK: 0001661059 (see all company filings)

IRS No.: 475231247 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38905 | Film No.: 221137064
SIC: 2834 Pharmaceutical Preparations